AI Monitoring Agent Delivers 82x ROI and $21 Million Gains in Cancer Drug Trials, Tufts Analysis Finds

AI Monitoring Agent Delivers 82x ROI and $21 Million Gains in Cancer Drug Trials, Tufts Analysis Finds | Health AI Central | Health AI Central